Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis

2012246 citationsReviewgreen Open Access

Authors

Audrey Mauguen

C. Le Péchoux

Michele I. Saunders

Steven E. Schild

Andrew T. Turrisi

Michaël Baumann · TU Dresden

Abstract

Patients with nonmetastatic NSCLC derived a significant OS benefit from accelerated or hyperfractionated radiotherapy; a similar but nonsignificant trend was observed for SCLC. As expected, there was increased acute esophageal toxicity.

Topics & Keywords

Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 30, Issue 22, pp. 2788-2797

DOI: 10.1200/jco.2012.41.6677

Field-Weighted Citation Impact: 21.24